Blog - Page 4079 of 5386

MondayNov 03, 2008 4:16 am

Aradigm Corporation (OTC BB: ARDM)

Aradigm Corporation (OTC BB: ARDM), an emerging specialty pharmaceutical company, is committed to developing and commercializing a portfolio of drugs designed to treat severe respiratory diseases. With its clinical expertise, targeted development efforts, and strength of a well accomplished leadership team, the company is poised to capitalize on niche opportunities for new and improved products used in the treatment of severe respiratory disease. For further information, visit the Company's web site at www.aradigm.com.

MondayNov 03, 2008 4:16 am

NAPCO Security Systems, Inc. (NASDAQ:NSSC)

NAPCO Security Systems, Inc. (NASDAQ:NSSC) is a leading manufacturer of a wide array of security products, developing advanced technologies for intrusion, fire, video, wireless, access control and door locking systems. With headquarters in New York, the company has branched into the international market by opening offices in the United Kingdom, the Caribbean, and Dubai. While many of NAPCO’s products have gained national attention, their Alarm Lock Division is the company’s fastest growing product and has been a leader in the marketplace since 1987. For further info, visit the company website at: www.napcosecurity.com.

MondayNov 03, 2008 4:15 am

Antigenics, Inc. (NASDAQ: AGEN)

Antigenics, Inc. (NASDAQ: AGEN) is focused on enhancing and extending the lives of patients by developing superior health care products for a broad array of cancers, infectious diseases and autoimmune disorders. Earlier this year, the company’s patient-specific cancer vaccine Oncophage ® (vitespen) was approved in Russia for the treatment of kidney cancer patients at intermediate risk for disease recurrence. Antigenics is now committed to exploring other major geographical territories for regulatory approval of Oncophage. For further information, visit the Company's web site at www.antigenics.com.

MondayNov 03, 2008 4:15 am

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS)

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS), a clinical-stage biopharmaceutical company, is focused on improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing two potentially complementary agents for the treatment of chronic hepatitis C: ANA598, a non-nucleoside polymerase inhibitor; and ANA773, an oral TLR7 agonist prodrug. For further information, visit the Company's web site at www.anadyspharma.com.

MondayNov 03, 2008 4:15 am

Nanogen, Inc. (NASDAQ: NGEN)

Nanogen, Inc. (NASDAQ: NGEN) is focused on developing diagnostic products that provide enhanced patient care. The company’s products are designed to offer faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These superior products include molecular diagnostic kits and reagents, as well as rapid test kits that can be utilized in urgent care settings or at the point-of-care. Nanogen is committed to bringing better results to diagnostics and healthcare. For further information, visit the Company's web site at www.nanogen.com.

MondayNov 03, 2008 4:14 am

Amerigo Resources Ltd. (TSX: ARG CN)

Amerigo Resources Ltd. (TSX: ARG CN), through its wholly owned subsidiary, Minera Valle Central (MVC), focuses on producing copper and molybdenum concentrates. This subsidiary is treating all the fresh tailings from El Teniente's present production and has the right to treat the higher grade tailings from a 200 million tonne in situ tailings impoundment. Amerigo aims to increase production on an annualized basis to approximately 60 million pounds of copper and 1 million pounds of molybdenum. For further information, visit the Company's web site at www.amerigoresources.com.

MondayNov 03, 2008 4:14 am

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) focuses its efforts on leveraging its proprietary technology to discover the structural secrets of complex sugars and other complex mixtures. The company’s novel approach to drug development and innovative tools have yielded a diversified product pipeline containing technology-enabled generic drugs, re-engineered drugs and novel drug candidates. Momenta’s strategic objective is to create near-term revenue opportunities that will fund longer-term discovery and development. For further information, visit the Company's web site at www.momentapharma.com.

MondayNov 03, 2008 4:14 am

American Tony Pharmaceutical, Inc. (OTC BB: AIMR)

American Tony Pharmaceutical, Inc. (OTC BB: AIMR), a manufacturer and distributor of pharmaceuticals and health care products in China, is focused on developing, manufacturing and marketing pharmaceutical and health care products through its wholly owned subsidiary, Harbin Tianmu Pharmaceutical Co., Ltd. ("Tianmu Pharmaceutical"). Founded in 1999 in Harbin, China, Tianmu Pharmaceutical operates all of its business activities in the People's Republic of China.

MondayNov 03, 2008 4:13 am

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI)

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI), a biopharmaceutical company, specializes in the emerging field of molecular medicine. The company is committed to applying innovations in the identification and targeting of disease to enhance patient healthcare by treating significant, but unmet medical needs. Their focus is on discovering, developing and commercializing novel radiotherapeutics and molecular imaging pharmaceuticals for initial application in the areas of oncology and cardiology. For further information, visit the Company's web site at www.molecularinsight.com.

MondayNov 03, 2008 4:13 am

American Oil & Gas, Inc. (AMEX: AEZ)

American Oil & Gas, Inc. (AMEX: AEZ), a Denver Colorado based energy company, engages in oil and gas exploration, development and acquisition primarily in the Rocky Mountain region. This region is believed to hold one of the largest undeveloped natural gas resources remaining in the continental U.S. The company has acquired interests in more than 500,000 gross acres in three core project areas. All projects are positioned where there has been historical evidence of Hydrocarbon existence. For further information, visit the Company's web site at www.americanoilandgasinc.com.

Site Search

Company Search

Aradigm Corporation (OTC BB: ARDM)

NAPCO Security Systems, Inc. (NASDAQ:NSSC)

Antigenics, Inc. (NASDAQ: AGEN)

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS)

Nanogen, Inc. (NASDAQ: NGEN)

Amerigo Resources Ltd. (TSX: ARG CN)

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)

American Tony Pharmaceutical, Inc. (OTC BB: AIMR)

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI)

American Oil & Gas, Inc. (AMEX: AEZ)

Market Basics

Newsletter Publishers

Public Companies